CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

December 31, 2024 11:00 PM AEDT | By Cision

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts — Image source: Kalkine Media

Recent News

Hawo’s Story: How One Mother Persevered To Feed Her Family

Analysts explain why Hims & Hers stock is crashing today

Coinbase shares rise as SEC set to drop case

Funnelmax: The Innovative, Versatile Tool Revolutionizing Multiple Ind...

SEOUL, South Korea, Dec. 31, 2024 /PRNewswire/ -- CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered with CGBIO to host the International Spine Endoscopy Training Course. The event welcomed 12 medical professionals from nine countries, including Mexico, Switzerland, and India. Led by Professor Jin-Sung Kim (also known as Luke) of Seoul St. Mary's Hospital, The Catholic University of Korea — a world-renowned expert in minimally invasive and endoscopic spine surgery — the program showcased Korea's leadership in advanced surgical techniques and medical device innovation.

CG MedTech and CGBIO Showcase Korea’s Spine Surgery Excellence to Global Experts

The training course featured advanced spine model simulators from Germany, Canada, and Italy. These simulators replicated human anatomical structures, including blood vessels, muscles, bones, and ligaments, providing participants with an unparalleled hands-on experience. The program focused on full-endoscopic and biportal endoscopic spine surgery, a minimally invasive technique that reduces recovery time and complications while enabling precise, multi-angle access. The involvement of global simulator manufacturers highlights the growing recognition of Korea's expertise in spine surgery.

Participants engaged in practical sessions led by Professors Jin-Sung Kim, Sang Hyun Han, and Jung Hoon Kim, which featured cutting-edge Korean medical devices. These included CG MedTech's Anax MIS System, designed for precise pedicle screw placement with minimal tissue disruption, and CGBIO's NOVOSIS, a bone substitute celebrated for its biocompatibility and effectiveness. Also showcased were CGDERM Spinkle, an anti-adhesion agent enhancing surgical safety, and the Excender expandable cage, praised for its innovative design that restores disc height and angle, even in challenging surgical environments.

"CG MedTech, with CGBIO, is committed to advancing global medical education by sharing innovative surgical methods and premium devices," said Ju Mi Chung, CEO of CG MedTech. "Our mission is to enhance the skills of medical professionals worldwide while strengthening Korea's leadership in this field."

The event, hosted by the Catholic University of Korea (International Skills Center), received support from the Ministry of Health and Welfare and the Korea Health Industry Development Institute. The Regional Domestic Medical Device Education and Training Support Center—Korea's first comprehensive training hub for medical devices—played a vital role in bridging government initiatives with industry collaboration.

Programs like this firmly establish Korea as a global hub for advanced medical technology and education. The collaboration between CG MedTech, CGBIO, and international institutions reaffirms Korea's commitment to innovation and its leadership in spine surgery education and technology.

CG MedTech and CGBIO Showcase Korea’s Spine Surgery Excellence to Global Experts

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Full Name

Mobile

By submitting your details above and clicking on the 'Download Report' button, you confirm that you are happy for one of the representatives of Kalkine Media or its group entities to contact you to discuss the services, consent to - our Terms & Conditions, and to receive marketing offers, including to be contacted by email or phone, as set out in our Privacy Policy. Any calls will be made by Kalkine group's telemarketing entities on our behalf or on behalf of Kalkine group entities.